US mRNA specialist Moderna has announced that the German Standing Committee on Vaccination (STIKO) has issued a ...

Swiss pharma giant Novartis (NOVN: VX) has announced a planned $23 billion investment over five years in US-based ...

Johnson & Johnson has announced new data from an analysis modelling long-term progression free survival (PFS) in transplant ...

Speculation about the US Administration’s views on the Benefits Scheme (PBS) has reconfirmed the sanctity of the PBS as the ...

Indian drugmaker Sun (BSE: 524715) shares were buzzing in trade on the last trading day of the week to April 11, rising as ...

US biotech giant Amgen (Nasdaq: AMGN) today announced a significant breakthrough with its global Phase III DeLLphi-304 ...

The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...

US biotech Imbria Pharmaceuticals has raised $57.5 million in a series B financing round to fund a new mid-stage trial of its ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s (LSE: AZN) Truqap ...

Late Thursday, the US Food and Drug Administration revealed it is taking a ground-breaking step to advance public health by ...

Australian biotech Opthea (Nasdaq: OPT) is cutting around two-thirds of its workforce, as the company moves to curb spending ...

US biopharma company Palatin Technologies (NYSE American: PTN) is at risk of being removed from the NYSE American exchange ...